Form 8-K - Current report:
SEC Accession No. 0001789769-25-000012
Filing Date
2025-03-04
Accepted
2025-03-04 07:14:03
Documents
25
Period of Report
2025-03-04
Items
Item 2.02: Results of Operations and Financial Condition
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K til-20250304.htm   iXBRL 8-K 34949
2 EX-99.1 a2024earningspressrelease.htm EX-99.1 87099
3 EX-99.2 instilbiocorppres2025030.htm EX-99.2 13671
7 image.jpg GRAPHIC 3565
8 instilbiocorppres2025030001.jpg GRAPHIC 85092
9 instilbiocorppres2025030002.jpg GRAPHIC 269409
10 instilbiocorppres2025030003.jpg GRAPHIC 143790
11 instilbiocorppres2025030004.jpg GRAPHIC 125852
12 instilbiocorppres2025030005.jpg GRAPHIC 114464
13 instilbiocorppres2025030006.jpg GRAPHIC 84932
14 instilbiocorppres2025030007.jpg GRAPHIC 98105
15 instilbiocorppres2025030008.jpg GRAPHIC 174062
16 instilbiocorppres2025030009.jpg GRAPHIC 96092
  Complete submission text file 0001789769-25-000012.txt   1925494

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT til-20250304.xsd EX-101.SCH 1773
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT til-20250304_lab.xml EX-101.LAB 22530
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT til-20250304_pre.xml EX-101.PRE 13038
27 EXTRACTED XBRL INSTANCE DOCUMENT til-20250304_htm.xml XML 2804
Mailing Address 3963 MAPLE AVENUE SUITE 350 DALLAS TX 75219
Business Address 3963 MAPLE AVENUE SUITE 350 DALLAS TX 75219 (972) 499-3350
Instil Bio, Inc. (Filer) CIK: 0001789769 (see all company filings)

EIN.: 832072195 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-40215 | Film No.: 25701529
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)